taurine has been researched along with Hematologic Malignancies in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Patients with haematological cancer who are expected to develop prolonged neutropenia (> 7 days) and who have a non-tunnelled CVC implanted will be randomised to receive prophylactic taurolidine-citrate-heparin solution using a lock technique (study group) or heparin alone (placebo group)." | 5.27 | Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT). ( Aguilar-Guisado, M; Arnan, M; Berbel, D; Carratalà, J; Cisneros-Herreros, JM; Encuentra, M; Gudiol, C; Martín-Gandul, C; Montero, I; Nicolae, S; Perayre, M; Royo-Cebrecos, C, 2018) |
| "Taurolidine has demonstrated inhibition of biofilm formation in vitro." | 2.77 | Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin. ( Funch, P; Fuursted, K; Handrup, MM; Møller, JK; Schrøder, H, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gudiol, C | 2 |
| Arnan, M | 2 |
| Aguilar-Guisado, M | 2 |
| Royo-Cebrecos, C | 2 |
| Sánchez-Ortega, I | 1 |
| Montero, I | 2 |
| Martín-Gandul, C | 2 |
| Laporte-Amargós, J | 1 |
| Albasanz-Puig, A | 1 |
| Nicolae, S | 2 |
| Perayre, M | 2 |
| Berbel, D | 2 |
| Tebe, C | 1 |
| Riera, J | 1 |
| Sureda, A | 1 |
| Cisneros, JM | 1 |
| Carratalà, J | 2 |
| Encuentra, M | 1 |
| Cisneros-Herreros, JM | 1 |
| Dümichen, MJ | 1 |
| Seeger, K | 1 |
| Lode, HN | 1 |
| Kühl, JS | 1 |
| Ebell, W | 1 |
| Degenhardt, P | 1 |
| Singer, M | 1 |
| Geffers, C | 1 |
| Querfeld, U | 1 |
| Härtel, C | 1 |
| Scholz, T | 1 |
| Kuhn, M | 1 |
| Bendiks, M | 1 |
| Göpel, W | 1 |
| Lauten, M | 1 |
| Herting, E | 1 |
| Handrup, MM | 1 |
| Fuursted, K | 1 |
| Funch, P | 1 |
| Møller, JK | 1 |
| Schrøder, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective, Randomized, Controlled Trial Evaluating the Efficacy of a Lock-therapy With a Solution of Taurolidine/Citrate (TauroLock) vs Standard Saline Solution for the Primary Prevention of Catheter-related Infections (CLI) in Adult Patients Wtih a Non[NCT02279121] | 162 participants (Actual) | Interventional | 2014-11-30 | Completed | |||
| "Lock sOlutiOnS for Epicutaneo-caval Catheters in Neonates: a LOOSEN Pilot Study"[NCT05729321] | 7 participants (Anticipated) | Observational [Patient Registry] | 2022-09-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for taurine and Hematologic Malignancies
| Article | Year |
|---|---|
A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients.
Topics: Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Citrates; Do | 2020 |
Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Topics: Anti-Infective Agents; Antineoplastic Agents; Catheter-Related Infections; Catheterization, Central | 2018 |
Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.
Topics: Adolescent; Anti-Infective Agents, Local; Anticoagulants; Bacteria; Catheter-Related Infections; Cat | 2012 |
Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.
Topics: Adolescent; Anti-Infective Agents, Local; Anticoagulants; Bacteria; Catheter-Related Infections; Cat | 2012 |
Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.
Topics: Adolescent; Anti-Infective Agents, Local; Anticoagulants; Bacteria; Catheter-Related Infections; Cat | 2012 |
Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.
Topics: Adolescent; Anti-Infective Agents, Local; Anticoagulants; Bacteria; Catheter-Related Infections; Cat | 2012 |
Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin.
Topics: Adolescent; Anti-Bacterial Agents; Anticoagulants; Antineoplastic Agents; Bacterial Infections; Biof | 2012 |
1 other study available for taurine and Hematologic Malignancies
| Article | Year |
|---|---|
Innate immune responses to Stenotrophomonas maltophilia in immunocompromised pediatric patients and the effect of taurolidine.
Topics: Adult; Antineoplastic Agents; Cytokines; Female; Flow Cytometry; Hematologic Neoplasms; Humans; Immu | 2013 |